|
|
|
LifeScienceHistory.com - Check us out on Instagram
California Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing CaliforniaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Principia BioPharma
| | | Phone: | (650) 416-7700 | Year Established: | 2008 | Main Contact: | Roy Hardiman, CBO | | Other Contacts: | Christopher Y. Chai, CFO David Goldstein, Ph.D., CSO Ken A. Brameld, Ph.D., VP, Drug Discovery Martin Babler, CEO Steve Gourlay, MBBS, FRACP, Ph.D., CMO
| | Company Description | Principia Biopharma is a private, pre-clinical stage company initially focused on the discovery and development of differentiated small molecule drugs targeting inflammatory/autoimmune diseases as well as cancer. The company expects to submit an IND for its lead program in 2013 and continues to invest in additional programs and its reversible covalent platform. Principia raised a $36.3 million Series A round of investment from a leading group of health care investors including New Leaf Venture Partners, OrbiMed Advisors, Morgenthaler Ventures, SROne and Mission Bay Capital. | |
|
|
|
|
|